Home Cartesian Therapeutics

Cartesian Therapeutics

acquired
Post-IPO Round
Pharmaceutical R&D Developer

Basic Information

Cartesian Therapeutics is a fully integrated clinical-stage biopharmaceutical company developing novel cellular and gene immunotherapies to treat cancer and autoimmune diseases. Cartesian’s vision is to cure diseases by RNA engineering of any cell to deliver any combination of therapies to any tissue. The company is a pioneer in RNA cellular therapies both within and beyond oncology and is currently developing products for the treatment of autoimmune, oncologic, and respiratory diseases.
Cartesian Therapeutics, Inc.
Maryland,United States of America
15~50 people
January 01, 2016
info@cartesiantx.com